These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24223657)

  • 41. Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals.
    Biró E; Nieuwland R; Tak PP; Pronk LM; Schaap MC; Sturk A; Hack CE
    Ann Rheum Dis; 2007 Aug; 66(8):1085-92. PubMed ID: 17261534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular complications in paediatric-onset systemic lupus erythematosus in Saudi Arabian patients.
    Azhar AS; Awlia OM; Muzaffer MA
    Clin Exp Rheumatol; 2017; 35(3):535-541. PubMed ID: 28229823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
    Zhao Q; Yang C; Wang J; Li Y; Yang P
    Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunological profile of erythema nodosum and their relationship of C-reactive protein level and erythrocyte sedimentation rate: A retrospective analysis of 61 patients.
    Cao C; Chen L; Li S; Wang Y; Yuan L
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):136-140. PubMed ID: 37114258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis.
    Fukami Y; Koike H; Iijima M; Mouri N; Nishi R; Katsuno M
    Muscle Nerve; 2022 Aug; 66(2):175-182. PubMed ID: 35581952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus.
    Kekow M; Barleben M; Drynda S; Jakubiczka S; Kekow J; Brune T
    BMC Musculoskelet Disord; 2013 Nov; 14():325. PubMed ID: 24245522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.
    Wu YL; Higgins GC; Rennebohm RM; Chung EK; Yang Y; Zhou B; Nagaraja HN; Birmingham DJ; Rovin BH; Hebert LA; Yu CY
    Adv Exp Med Biol; 2006; 586():227-47. PubMed ID: 16893076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.
    Shields KJ; Mollnes TE; Eidet JR; Mikkelsen K; Almdahl SM; Bottazzi B; Lyberg T; Manzi S; Ahearn JM; Hollan I
    PLoS One; 2017; 12(3):e0174577. PubMed ID: 28362874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.
    Lin J; Li N; Chen H; Liu C; Yang B; Ou Q
    Medicine (Baltimore); 2015 May; 94(19):e834. PubMed ID: 25984669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic lupus erythematosus in childhood correlations between changes in disease activity and serum complement levels.
    Singsen BH; Bernstein BH; King KK; Hanson V
    J Pediatr; 1976 Sep; 89(3):358-69. PubMed ID: 956959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
    Narumi S; Takeuchi T; Kobayashi Y; Konishi K
    Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
    Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
    Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins.
    Lacki JK; Samborski W; Mackiewicz SH
    Clin Rheumatol; 1997 May; 16(3):275-8. PubMed ID: 9184265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6.
    Suh CH; Chun HY; Ye YM; Park HS
    Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial clustering of non-nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus.
    Hunnangkul S; Nitsch D; Rhodes B; Chadha S; Roberton CA; Pessôa-Lopes P; Norsworthy PJ; Fernando MM; Charles P; Mackworth-Young C; Isenberg DA; Whittaker JC; Vyse TJ
    Arthritis Rheum; 2008 Apr; 58(4):1116-24. PubMed ID: 18383369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyponatremia as an Inflammatory Marker of Lupus Activity Is a Fact or Fad: A Cross-Sectional Study.
    Yamany A; Behiry ME; Ahmed SA
    Open Access Rheumatol; 2020; 12():29-34. PubMed ID: 32210647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.
    Grennan DM; Moseley A; Sloane D; Pumphrey R; Dick WC; Buchanan WW
    Aust N Z J Med; 1977 Dec; 7(6):625-9. PubMed ID: 306817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.